↓ Skip to main content

Recent advances of IDH1 mutant inhibitor in cancer therapy

Overview of attention for article published in Frontiers in Pharmacology, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recent advances of IDH1 mutant inhibitor in cancer therapy
Published in
Frontiers in Pharmacology, August 2022
DOI 10.3389/fphar.2022.982424
Pubmed ID
Authors

Wangqi Tian, Weitong Zhang, Yifan Wang, Ruyi Jin, Yuwei Wang, Hui Guo, Yuping Tang, Xiaojun Yao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 10%
Student > Postgraduate 2 6%
Student > Ph. D. Student 2 6%
Professor 1 3%
Lecturer > Senior Lecturer 1 3%
Other 1 3%
Unknown 21 68%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 16%
Medicine and Dentistry 3 10%
Neuroscience 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Unknown 21 68%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2022.
All research outputs
#19,869,877
of 24,417,958 outputs
Outputs from Frontiers in Pharmacology
#9,335
of 18,392 outputs
Outputs of similar age
#308,235
of 420,122 outputs
Outputs of similar age from Frontiers in Pharmacology
#602
of 1,416 outputs
Altmetric has tracked 24,417,958 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,392 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,122 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,416 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.